about
Advances in using MRI probes and sensors for in vivo cell tracking as applied to regenerative medicineDe novo determination of peptide structure with solid-state magic-angle spinning NMR spectroscopy.High-resolution molecular structure of a peptide in an amyloid fibril determined by magic angle spinning NMR spectroscopyDeveloping imidazoles as CEST MRI pH sensorsCEST theranostics: label-free MR imaging of anticancer drugsTime domain removal of irrelevant magnetization in chemical exchange saturation transfer Z-spectra.Variable delay multi-pulse train for fast chemical exchange saturation transfer and relayed-nuclear overhauser enhancement MRI.Noninvasive imaging of infection after treatment with tumor-homing bacteria using Chemical Exchange Saturation Transfer (CEST) MRI.Diamagnetic chemical exchange saturation transfer (diaCEST) liposomes: physicochemical properties and imaging applicationsNon-invasive temperature mapping using temperature-responsive water saturation shift referencing (T-WASSR) MRIAnthranilic acid analogs as diamagnetic CEST MRI contrast agents that feature an intramolecular-bond shifted hydrogen.Developing MR probes for molecular imaging.Tuning phenols with Intra-Molecular bond Shifted HYdrogens (IM-SHY) as diaCEST MRI contrast agentsSimultaneous water and lipid suppression for in vivo brain spectroscopy in humans.Chemical Exchange Saturation Transfer (CEST) Agents: Quantum Chemistry and MRI.Salicylic Acid Conjugated Dendrimers Are a Tunable, High Performance CEST MRI NanoPlatformCEST-MRI detects metabolite levels altered by breast cancer cell aggressiveness and chemotherapy responseArtificial reporter gene providing MRI contrast based on proton exchange.Size-induced enhancement of chemical exchange saturation transfer (CEST) contrast in liposomesIndirect detection of labile solute proton spectra via the water signal using frequency-labeled exchange (FLEX) transfer.High-throughput screening of chemical exchange saturation transfer MR contrast agentsVaginal delivery of paclitaxel via nanoparticles with non-mucoadhesive surfaces suppresses cervical tumor growth.Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cellsMonitoring enzyme activity using a diamagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent.CEST phase mapping using a length and offset varied saturation (LOVARS) scheme.Nuts and bolts of chemical exchange saturation transfer MRI.Natural D-glucose as a biodegradable MRI relaxation agent.Liposome-based mucus-penetrating particles (MPP) for mucosal theranostics: demonstration of diamagnetic chemical exchange saturation transfer (diaCEST) magnetic resonance imaging (MRI).Establishing the Lysine-rich Protein CEST Reporter Gene as a CEST MR Imaging Detector for Oncolytic Virotherapy.Steady pulsed imaging and labeling scheme for noninvasive perfusion imagingDynamic glucose enhanced (DGE) MRI for combined imaging of blood-brain barrier break down and increased blood volume in brain cancer.Screening CEST contrast agents using ultrafast CEST imaging.MR tracking of transplanted cells with "positive contrast" using manganese oxide nanoparticles.Salicylic acid and analogues as diaCEST MRI contrast agents with highly shifted exchangeable proton frequenciesA diaCEST MRI approach for monitoring liposomal accumulation in tumorsScreening of CEST MR contrast agents.Human protamine-1 as an MRI reporter gene based on chemical exchange.Optimization of SABRE for polarization of the tuberculosis drugs pyrazinamide and isoniazid.Label-free in vivo molecular imaging of underglycosylated mucin-1 expression in tumour cellsMulti-echo length and offset VARied saturation (MeLOVARS) method for improved CEST imaging.
P50
Q26863117-8736F490-E509-42E6-98ED-F9B953B9A619Q27639440-FE804CBB-D77D-46C3-A86D-3062192B54A0Q27642920-15E2B1B9-858D-44AB-871D-F818FF7418F8Q28818324-9D2ACC4C-03B7-4FDA-B23B-D10C73BEAB25Q28833807-9715348E-15F5-4C55-9F35-6A5B999F439CQ30651480-8242EEEC-D548-4D89-98FD-7E67A5430B57Q30652440-0162E900-F246-46AD-BD03-73021EC1226DQ30677182-8B12C9C8-8D87-4DBA-880E-ED01302B8F50Q30715520-442AE804-1AB1-49C5-AAD0-453546D3CE9EQ30727212-E42CB328-00C8-4F7E-8E1B-5AAF78B6B13EQ30810294-0C47A46A-1DC6-4C63-B18F-91F8C9FD6AE6Q30857741-25C9A15B-6A2A-4732-B330-0E63F6249045Q30859038-2D94A7F9-8205-44BF-88BC-932DD2AB95EDQ30998703-BBA108D3-555F-4319-922C-8BE06D8C2D0CQ31029179-CE1A75C5-C295-4372-A6AA-4EF4556A3549Q31048798-B99E782E-88E3-4E7B-AB11-E84AD3C8F2C3Q31082468-0C933BBD-BB84-4755-ABD3-AE141865ECB3Q31096293-D7715573-A519-4057-8844-C6AC4D27C5BEQ31150456-242F4A27-529F-41B9-B6FE-DCA0B86990FFQ33526009-82123934-47ED-4430-9216-7130122F0479Q33619490-F37D1CA8-5C75-4490-A585-9B54484C06DCQ33763847-4829DBDE-15B8-4F26-8D15-8E9839BC566EQ33818503-A65711B5-A0D0-410D-BF14-3B2E72F02822Q34020035-6E410FB4-FAF9-4AA4-841C-794511270158Q34127991-9AB2886E-FA8A-40DD-9EC9-06794E336513Q34543331-6A199229-2887-405B-977A-CF4466942E12Q34574936-9B8C4864-795B-4613-8659-C2B503BB81ECQ35088353-6D0268D0-5E41-4AD2-BCCD-1AA88E3716D7Q35670672-C8DA29E7-0822-465E-8D93-F5C087432184Q36021935-41238E09-8934-4045-A690-7BF6FDBC251DQ36470172-B3421CFE-AAFA-4B3F-9B43-C5E063D7D143Q36759347-0F649090-0593-4FF0-A7BE-944ACB8F3BA9Q36953715-AACCF5B7-8CD3-408B-B554-24D986F6362EQ37284368-FA0D9F9B-5232-4C92-B0D8-493CEEED02D2Q37725101-D7EBDDF2-0CC8-4E85-8910-6DB46D6B2684Q38577489-705088E8-E433-4463-84A3-8703922042A7Q38730687-6855E606-7C57-4709-A3C6-7AFF52B99407Q38789427-CD9D7F57-5959-4A04-80D5-F40CA074DE4FQ38894517-3AA3A567-A977-4487-A54E-BA51C65607EEQ38927828-8AF917DF-C9CC-494F-8A2C-AD9990A2CC90
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Michael T. McMahon
@ast
Michael T. McMahon
@en
Michael T. McMahon
@es
Michael T. McMahon
@sl
type
label
Michael T. McMahon
@ast
Michael T. McMahon
@en
Michael T. McMahon
@es
Michael T. McMahon
@sl
altLabel
M McMahon
@en
M T McMahon
@en
M. McMahon
@en
M. T. McMahon
@en
McMahon M
@en
McMahon M. T.
@en
McMahon M.
@en
McMahon MT
@en
McMahon
@en
Michael McMahon
@en
prefLabel
Michael T. McMahon
@ast
Michael T. McMahon
@en
Michael T. McMahon
@es
Michael T. McMahon
@sl
P108
P244
P1053
B-5942-2008
P106
P108
P1153
55168544400
P21
P214
1166149296185180670009
P244
n2017183329
P31
P3829
P496
0000-0002-8917-7640
P734
P735
P7859
lccn-n2017183329